Drug Therapy and Follow-Up
Publisher
Springer New York
Reference252 articles.
1. Hiatt, W.R., Goldstone, J., Smith, S.C., Jr., McDermott, M., Moneta, G., Oka, R., Newman, A.B., Pearce, W.H.: Atherosclerotic peripheral vascular disease symposium II: nomenclature for vascular diseases. Circulation 118 (2008) 2826–2829 2. Adams, R.J., Chimowitz, M.I., Alpert, J.S., Awad, I.A., Cerqueria, M.D., Fayad, P., Taubert, K.A.: Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke 34 (2003) 2310–2322 3. Kannel, W.B.: Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1 (1994) 333–339 4. Haffner, S.M., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229–234 5. Chapman, M.J.: From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Pharmacol Ther 113 (2007) 184–196
|
|